{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T11:16:02Z","timestamp":1780398962994,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Nederlandse Hartstichting","doi-asserted-by":"publisher","award":["2019T067"],"award-info":[{"award-number":["2019T067"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","atherosclerosis-journal.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.atherosclerosis.2024.118567","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T03:41:35Z","timestamp":1724384495000},"page":"118567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Treatment with APAC, a dual antiplatelet anticoagulant heparin proteoglycan mimetic, limits early collar-induced carotid atherosclerotic plaque development in Apoe\u2212\/\u2212 mice"],"prefix":"10.1016","volume":"397","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1242-1959","authenticated-orcid":false,"given":"Ilze","family":"Bot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Delfos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmeralda","family":"Hemme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia N.A.","family":"Bernab\u00e9 Kleijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"van Santbrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda C.","family":"Foks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petri T.","family":"Kovanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annukka","family":"Jouppila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riitta","family":"Lassila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2024.118567_bib1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0038-1657526","article-title":"Tissue factor in the pathogenesis of atherosclerosis","volume":"78","author":"Taubman","year":"1997","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/pgmj.36.414.226","article-title":"The thrombogenic hypothesis and its implications","volume":"36","author":"Duguid","year":"1960","journal-title":"Postgrad. Med."},{"issue":"Suppl K","key":"10.1016\/j.atherosclerosis.2024.118567_bib4","first-page":"2","article-title":"Atherogenesis and inflammation","volume":"14","author":"Jang","year":"1993","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis--an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib6","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1161\/01.ATV.13.12.1738","article-title":"The severity of atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin","volume":"13","author":"Lassila","year":"1993","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib7","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1161\/01.CIR.90.4.1669","article-title":"Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture","volume":"90","author":"Kaartinen","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib8","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1093\/eurheartj\/eht186","article-title":"Mast cells in human carotid atherosclerotic plaques are associated with intraplaque microvessel density and the occurrence of future cardiovascular events","volume":"34","author":"Willems","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejphar.2017.10.013","article-title":"Mast cells in atherosclerotic cardiovascular disease - activators and actions","volume":"816","author":"Kovanen","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.918305","article-title":"Mast cell and basophil granule proteases - in vivo targets and function","volume":"13","author":"Hellman","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib11","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1161\/01.ATV.17.12.3578","article-title":"Native macromolecular heparin proteoglycans exocytosed from stimulated rat serosal mast cells strongly inhibit platelet-collagen interactions","volume":"17","author":"Lassila","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib12","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1161\/01.ATV.20.11.e113","article-title":"Collagen-immobilized native macromolecular heparin proteoglycans strongly inhibit platelet interactions under flowing blood","volume":"20","author":"Kauhanen","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib13","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1055\/s-0037-1615075","article-title":"Effects of skin mast cells on bleeding time and coagulation activation at the site of platelet plug formation","volume":"79","author":"Kauhanen","year":"1998","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0037-1612980","article-title":"Topically administered macromolecular heparin proteoglycans effectively inhibit thrombus growth in microvascular anastomoses","volume":"87","author":"Olsson","year":"2002","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib15","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1055\/s-0034-1395157","article-title":"Mast cell-derived heparin proteoglycans as a model for a local antithrombotic","volume":"40","author":"Lassila","year":"2014","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib16","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s10157-016-1308-2","article-title":"Dual antiplatelet and anticoagulant APAC prevents experimental ischemia-reperfusion-induced acute kidney injury","volume":"21","author":"Tuuminen","year":"2017","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00701-024-06017-x","article-title":"Pretreatment with a dual AntiPlatelet and AntiCoagulant APAC reduces ischemia-reperfusion injury in a mouse model of temporary middle cerebral artery occlusion - implications for neurovascular procedures","volume":"166","author":"Denorme","year":"2024","journal-title":"Acta Neurochir."},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib18","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.ejvs.2019.05.019","article-title":"Novel locally acting dual antiplatelet and anticoagulant (APAC) targets multiple sites of vascular injury in an experimental porcine model","volume":"58","author":"Barreiro","year":"2019","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/432080","article-title":"Evaluation of plaque stability of advanced atherosclerotic lesions in apo E-deficient mice after treatment with the oral factor Xa inhibitor rivaroxaban","volume":"2011","author":"Zhou","year":"2011","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib20","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1038\/s41598-019-40602-w","article-title":"Targeting coagulation factor Xa promotes regression of advanced atherosclerosis in apolipoprotein-E deficient mice","volume":"9","author":"Posthuma","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ahj.2023.01.008","article-title":"Total events and net clinical benefit of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: the COMPASS trial","volume":"258","author":"Branch","year":"2023","journal-title":"Am. Heart J."},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib22","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/01.CIR.103.8.1164","article-title":"Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice","volume":"103","author":"von der Th\u00fcsen","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/FJC.0000000000001080","article-title":"Safety and functional pharmacokinetic profile of APAC, a novel intravascular antiplatelet and anticoagulant","volume":"78","author":"Craige","year":"2021","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.thromres.2023.04.010","article-title":"Intravenously administered APAC, a dual AntiPlatelet AntiCoagulant, targets arterial injury site to inhibit platelet thrombus formation and tissue factor activity in mice","volume":"228","author":"Bonetti","year":"2023","journal-title":"Thromb. Res."},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.thromres.2018.07.026","article-title":"Dual antiplatelet and anticoagulant (APAC) heparin proteoglycan mimetic with shear-dependent effects on platelet-collagen binding and thrombin generation","volume":"169","author":"Chen","year":"2018","journal-title":"Thromb. Res."},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3343\/alm.2015.35.1.15","article-title":"Influence of blood lipids on global coagulation test results","volume":"35","author":"Kim","year":"2015","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib27","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1161\/atvb.25.8.1736","article-title":"Role of the intrinsic coagulation pathway in atherogenesis assessed in hemophilic apolipoprotein E knockout mice","volume":"25","author":"Khallou-Laschet","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib28","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1161\/ATVBAHA.115.306954","article-title":"Factor XI deficiency protects against atherogenesis in apolipoprotein E\/factor XI double knockout mice","volume":"36","author":"Shnerb","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2017.09.013","article-title":"Platelet-derived chemokines in inflammation and atherosclerosis","volume":"122","author":"Bakogiannis","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib30","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1073\/pnas.061615598","article-title":"Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis","volume":"98","author":"Borsig","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib31","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MOL.0000000000000330","article-title":"The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity","volume":"27","author":"Bor\u00e9n","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib32","first-page":"389","article-title":"Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities","volume":"16","author":"B\u00e4ck","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib33","first-page":"159","article-title":"Porcine von Willebrand disease: implications for the pathophysiology of atherosclerosis and thrombosis","volume":"8","author":"Fuster","year":"1986","journal-title":"Prog. Hemost. Thromb."},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib34","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood.V98.5.1424","article-title":"Localized reduction of atherosclerosis in von Willebrand factor-deficient mice","volume":"98","author":"Methia","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib35","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.blre.2012.05.002","article-title":"Von Willebrand factor deficiency and atherosclerosis","volume":"26","author":"van Galen","year":"2012","journal-title":"Blood Rev."},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib36","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1182\/blood-2016-07-692673","article-title":"Platelets and von Willebrand factor in atherogenesis","volume":"129","author":"Wu","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib37","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.114.002765","article-title":"Molecular Imaging of Platelet-Endothelial Interactions and Endothelial von Willebrand Factor in Early and Mid-Stage Atherosclerosis","volume":"8","author":"Shim","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib38","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/ATVBAHA.122.318884","article-title":"Elevated LDL cholesterol increases microvascular endothelial VWF and thromboinflammation after myocardial infarction","volume":"43","author":"Ozawa","year":"2023","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.118567_bib39","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1182\/blood.2023019749","article-title":"Low-density lipoprotein promotes microvascular thrombosis by enhancing von Willebrand factor self-association","volume":"142","author":"Chung","year":"2023","journal-title":"Blood"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024011390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024011390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T13:55:23Z","timestamp":1727704523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915024011390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":39,"alternative-id":["S0021915024011390"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.118567","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with APAC, a dual antiplatelet anticoagulant heparin proteoglycan mimetic, limits early collar-induced carotid atherosclerotic plaque development in Apoe\u2212\/\u2212 mice","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.118567","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"118567"}}